期刊文献+

rhPTH加速上颌前部截骨术后正畸牙移动中的实验研究

Study of recombinant human parathyroid hormone to accelerate orthodontic tooth movement after anterior maxillary osteotomy
下载PDF
导出
摘要 目的:研究重组人甲状旁腺激素(recombinant human parathyroid hormone,rhPTH)促进上颌前部截骨术后正畸牙移动的可行性及其调控机制。方法:48只兔建立上颌前部截骨术及右侧上颌第一磨牙正畸移动模型,随机分成实验组和对照组。实验组术后隔日皮下注射rhPTH 20μg/kg;对照组隔日皮下注射等量生理盐水。2组分别于第5、7、14及21天测量右侧上颌第一磨牙向近中移动的距离,并取移动牙近中牙周组织行抗酒石酸酸性磷酸酶(tartrate resistant acid phosphatase,TRAP)染色破骨细胞计数、免疫组化和荧光定量PCR检测骨硬化蛋白(sclerostin,SOST)、骨形态蛋白-2(bone morphogenetic protein-2,BMP-2)的表达及变化。结果:在同一时间段,实验组右上颌第一磨牙移动距离及速度均快于对照组(P<0.05)。实验组右上颌第一磨牙的近中牙周组织中表达的破骨细胞计数明显大于对照组(P<0.05)。免疫组化和荧光定量PCR(fluorescence quantitative polymerase chain reaction,qPCR)检测发现,实验组右上颌第一磨牙近中牙周组织中SOST mRNA及蛋白的表达明显大于对照组(P<0.05);而实验组BMP-2 mRNA及蛋白的表达则低于对照组(P<0.05)。结论:隔日皮下注射rhPTH可能通过上调正畸牙近中压力侧SOST的表达,下调BMP-2的表达,增加牙槽骨的改建从而加快上颌前部截骨术后正畸牙的移动速度。 Objective:To study the feasibility and regulation mechanism of recombinant human parathyroid hormone(rhPTH)for promoting orthodontic tooth movement after the maxillary anterior osteotomy.Methods:Forty-eight rabbits were used to establish the model of anterior maxillary osteotomy and orthodontical movement of right maxillary first molars.They were randomly divided into the experimental group and the control group.The experimental group received subcutaneous injection of rhPTH 20μg/kg,while the control group received the normal saline every other day.The mesial movement distance of the right maxillary first molars was measured on the 5th,7th,14th and 21th day.The mesio-periodontium of moving teeth were taken and tartrate resistant acid phosphatase(TRAP)staining of osteoclast count,immunohistochemistry and fluorescence quantitative polymerase chain reaction(qPCR)of sclerostin(SOST)and bone morphogenetic protein-2(BMP-2)were performed.Results:During the same period,the moving distance and speed of the first molars in the experimental group were faster than those in the control group(P<0.05).In the mesial periodontal tissue of right maxillary first molars,the osteoclast count in the experimental group was significantly larger than that in the control group(P<0.05).According to the immunohistochemistry and qPCR,the expression of SOST mRNA and protein of the mesial periodontal tissue of right maxillary first molars in the experimental group was significantly higher than that in the control group(P<0.05),while the expression of BMP-2 mRNA and protein in the experimental group was lower than that in the control group(P<0.05).Conclusion:In the proximal pressure side of the orthodontic tooth after maxillary anterior osteotomy,subcutaneous injection of rhPTH on every other day may increase the alveolar bone remodeling to accelerate the movement speed of orthodontic tooth by upregulating the expression of SOST,downregulating the expression of BMP-2 and increasing the reconstruction of alveolar bone.
作者 陈小燕 唐正龙 李耀 王冬香 高琼 Chen Xiaoyan;Tang Zhenglong;Li Yao;Wang Dongxiang;Gao Qiong(Department of Oral and Maxillofacial Surgery,Stomatological Hospital of Guizhou Medical University)
出处 《重庆医科大学学报》 CAS CSCD 北大核心 2020年第11期1521-1527,共7页 Journal of Chongqing Medical University
基金 国家自然科学基金资助项目(编号:81460101)。
关键词 重组人甲状旁腺激素 上颌前部截骨术 正畸牙移动 SOST BMP-2 recombinant human parathyroid hormone(rh-PTH) anterior maxillary osteotomy orthodontic movement tooth sclerostin(SOST) bone morphogenetic protein-2(BMP-2)
  • 相关文献

参考文献3

二级参考文献44

  • 1李冰,陈宁,苗登顺,刘来奎,江宏兵.甲状旁腺素相关蛋白对小鼠颌骨来源成骨细胞增殖分化的影响[J].口腔医学,2006,26(2):133-136. 被引量:1
  • 2邹锦慧,李景田,何文英,张慧明,周小璜,李伯灵,李沐吉.甲状旁腺素和二膦酸盐对骨密度和骨生物力学的影响[J].解剖学杂志,2006,29(3):332-335. 被引量:3
  • 3Li X, Zhang Y, Kang H etal. Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. J Biol Chem 2005; 280(20): 19883-19887.
  • 4Baron R, Kneissel M. WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med2013; 19(2): 179-192.
  • 5van Bezooijen RL, Roelen BA, Visser A et al. Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist. J Exp Med 2004; 199(6): 805-814.
  • 6Brunkow ME, Gardner JC, van Ness Jet al. Bone dysplasia sclerosteosis results from loss of the SOSTgene product, a novel cystine knot-containing protein. Am J Hum Genet 2001; 68(3): 577-589.
  • 7Balemans W, Patel N, Ebeling Metal. Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease. J Med Genet 2002; 39(2): 91- 97.
  • 8Gardner JC, van Bezooijen RL, Mervis Bet al. Bone mineral density in sclerosteosis; affected individuals and gene carriers. J Clin Endocrinol Metab 2005; 90(12): 6392- 6395.
  • 9Stephen LX, Hamersma H, Gardner Jet al. Dental and oral manifestations of sclerosteosis. IntDentJ2001; 51(4): 287-290.
  • 10van Bezooijen RL, Bronckers AL, Gortzak RA etal. Sclerostin in mineralized matrices and van Buchem disease. J Dent Res 2009; 88(6): 569-574.

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部